Unlike traditional anti-angiogenic therapies that target VEGF, Sylentis developed SYL1801, an siRNA targeting NOTCH Regulated Ankyrin Repeat Protein (NRARP), to prevent and control nAMD progression
doi: 10.1093/femsre/fuaa060 27 DanchikC.CasadevallA
Non-Economic Damages These are the intangible, personal losses that have no simple price tag
Leptin and Ghrelin Hormonal imbalances involving leptin and ghrelin, two hormones that regulate appetite, can significantly contribute to overeating, which is a leading cause of weight gain
Patients with a history of severe gastrointestinal disease, particularly those with inflammatory bowel disease, severe gastroesophageal reflux disease, or history of pancreatitis, require careful evaluation before considering this therapy
Whilst mild, occasional acid reflux can often be managed with lifestyle modifications and over-the-counter remedies, certain symptoms warrant prompt medical evaluation